The emerging role of furin in neurodegenerative and neuropsychiatric diseases.
Yi ZhangXiaoqin GaoXue BaiShanshan YaoYan-Zhong ChangGuofen GaoPublished in: Translational neurodegeneration (2022)
Furin is an important mammalian proprotein convertase that catalyzes the proteolytic maturation of a variety of prohormones and proproteins in the secretory pathway. In the brain, the substrates of furin include the proproteins of growth factors, receptors and enzymes. Emerging evidence, such as reduced FURIN mRNA expression in the brains of Alzheimer's disease patients or schizophrenia patients, has implicated a crucial role of furin in the pathophysiology of neurodegenerative and neuropsychiatric diseases. Currently, compared to cancer and infectious diseases, the aberrant expression of furin and its pharmaceutical potentials in neurological diseases remain poorly understood. In this article, we provide an overview on the physiological roles of furin and its substrates in the brain, summarize the deregulation of furin expression and its effects in neurodegenerative and neuropsychiatric disorders, and discuss the implications and current approaches that target furin for therapeutic interventions. This review may expedite future studies to clarify the molecular mechanisms of furin deregulation and involvement in the pathogenesis of neurodegenerative and neuropsychiatric diseases, and to develop new diagnosis and treatment strategies for these diseases.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- poor prognosis
- peritoneal dialysis
- infectious diseases
- prognostic factors
- resting state
- bipolar disorder
- multiple sclerosis
- white matter
- squamous cell carcinoma
- functional connectivity
- young adults
- patient reported outcomes
- long non coding rna
- papillary thyroid
- current status
- squamous cell